These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Metabolism of the failing heart. Katz AM Cardioscience; 1993 Dec; 4(4):199-203. PubMed ID: 8298061 [TBL] [Abstract][Full Text] [Related]
5. Is angiotensin II a growth factor masquerading as a vasopressor? Katz AM Heart Dis Stroke; 1992; 1(3):151-4. PubMed ID: 1344101 [TBL] [Abstract][Full Text] [Related]
6. Heart failure in 2001: a prophecy. Katz AM Am J Cardiol; 1992 Oct; 70(10):126C-131C. PubMed ID: 1414889 [TBL] [Abstract][Full Text] [Related]
7. The heart in congestive failure. Katz AM Cardioscience; 1990 Mar; 1(1):3-6. PubMed ID: 2151711 [TBL] [Abstract][Full Text] [Related]
8. Heart failure and Starling's Law of the heart. ter Keurs HE Can J Cardiol; 1996 Oct; 12(10):1047-57. PubMed ID: 9191498 [TBL] [Abstract][Full Text] [Related]
9. Role of growth hormone in chronic heart failure: therapeutic implications. Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515 [TBL] [Abstract][Full Text] [Related]
10. Cardiocirculatory dynamics in the normal and failing heart. Zelis R; Flaim SF; Liedtke AJ; Nellis SH Annu Rev Physiol; 1981; 43():455-76. PubMed ID: 6452090 [TBL] [Abstract][Full Text] [Related]
11. [Changes in gene expression in terminal myocardial failure]. Eschenhagen T; Mende U; Schmitz W; Scholz H Z Kardiol; 1992; 81 Suppl 4():33-40. PubMed ID: 1290304 [TBL] [Abstract][Full Text] [Related]
12. Heart failure: an update on pathophysiology. Drexler H Arch Mal Coeur Vaiss; 1994 Jun; 87 Spec No 2():13-6. PubMed ID: 7864717 [TBL] [Abstract][Full Text] [Related]
13. Effects of growth hormone and insulin-like growth factor I in experimental heart failure. Ross J; Ryoke T Growth Horm IGF Res; 1998 Apr; 8 Suppl B():159-61. PubMed ID: 10990154 [TBL] [Abstract][Full Text] [Related]
14. Maladaptive growth in the failing heart: the cardiomyopathy of overload. Katz AM Cardiovasc Drugs Ther; 2002 May; 16(3):245-9. PubMed ID: 12374903 [TBL] [Abstract][Full Text] [Related]
16. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. Paulus WJ; Tschöpe C J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677 [TBL] [Abstract][Full Text] [Related]
17. Energy requirements of contraction and relaxation: implications for inotropic stimulation of the failing heart. Katz AM Basic Res Cardiol; 1989; 84 Suppl 1():47-53. PubMed ID: 2530976 [TBL] [Abstract][Full Text] [Related]
18. Altered expression of titin and contractile proteins in failing human myocardium. Hein S; Scholz D; Fujitani N; Rennollet H; Brand T; Friedl A; Schaper J J Mol Cell Cardiol; 1994 Oct; 26(10):1291-306. PubMed ID: 7869390 [TBL] [Abstract][Full Text] [Related]
19. Subcellular remodeling as a viable target for the treatment of congestive heart failure. Dhalla NS; Dent MR; Tappia PS; Sethi R; Barta J; Goyal RK J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):31-45. PubMed ID: 16703218 [TBL] [Abstract][Full Text] [Related]
20. Molecular and cellular mechanisms of myocardial failure. Colucci WS Am J Cardiol; 1997 Dec; 80(11A):15L-25L. PubMed ID: 9412539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]